{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:08:29Z","timestamp":1790186909320,"version":"4.1.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1001\/jamaneurol.2018.4775","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T17:18:49Z","timestamp":1549905529000},"page":"552","source":"Crossref","is-referenced-by-count":46,"title":["Association Between <i>ABCB1<\/i> Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack"],"prefix":"10.1001","volume":"76","author":[{"given":"Yuesong","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China"},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China"},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China"},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China"},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Claiborne","family":"Johnston","sequence":"additional","affiliation":[{"name":"Dean\u2019s Office, Dell Medical School, University of Texas at Austin, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassome","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (URCEST-CRC-CRB), Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"Department of Clinical Pharmacology, Sorbonne Universit\u00e9, Paris, France"},{"name":"FACT (French Alliance for Cardiovascular Clinical Trials), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China"},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China"},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wang","sequence":"additional","affiliation":[{"name":"Illinois Neurological Institute Stroke Network, OSF Healthcare System, Peoria, Illinois"},{"name":"Department of Neurology, University of Illinois College of Medicine at Peoria, Peoria, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China"},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China"},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events (CHANCE) Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"noi180108r1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"noi180108r2","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"3","key":"noi180108r3","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"issue":"2","key":"noi180108r4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1586\/ern.10.203","article-title":"Antiplatelet resistance in stroke.","volume":"11","author":"Top\u00e7uoglu","year":"2011","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"noi180108r5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/ane.2013.128.issue-4","article-title":"Clinical consequences of aspirin and clopidogrel resistance: an overview.","volume":"128","author":"Mijajlovic","year":"2013","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"noi180108r6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/hrt.2011.227652","article-title":"Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel.","volume":"98","author":"Zabalza","year":"2012","journal-title":"Heart"},{"issue":"4","key":"noi180108r7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events.","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"noi180108r8","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/STROKEAHA.113.000823","article-title":"CYP2C19 polymorphisms and antiplatelet effects of clopidogrel in acute ischemic stroke in China.","volume":"44","author":"Jia","year":"2013","journal-title":"Stroke"},{"issue":"1","key":"noi180108r9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis.","volume":"135","author":"Pan","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"noi180108r10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack.","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"noi180108r11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1592\/phco.30.3.265","article-title":"Genetic causes of clopidogrel nonresponsiveness: which ones really count?","volume":"30","author":"Momary","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"9749","key":"noi180108r12","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S0140-6736(10)61273-1","article-title":"Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.","volume":"376","author":"Mega","year":"2010","journal-title":"Lancet"},{"issue":"16","key":"noi180108r13","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2011.1529","article-title":"Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis.","volume":"306","author":"Cayla","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"noi180108r14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/CIRCINTERVENTIONS.111.962555","article-title":"Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin.","volume":"4","author":"Jeong","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"9749","key":"noi180108r15","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/S0140-6736(10)61274-3","article-title":"Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"noi180108r16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3892\/etm.2014.2058","article-title":"Risk factors for clopidogrel resistance in patients with ischemic cerebral infarction and the correlation with ABCB1 gene rs1045642 polymorphism.","volume":"9","author":"Su","year":"2015","journal-title":"Exp Ther Med"},{"issue":"2","key":"noi180108r17","doi-asserted-by":"publisher","first-page":"e0148891","DOI":"10.1371\/journal.pone.0148891","article-title":"Association of PON1, P2Y12 and COX1 with recurrent ischemic events in patients with extracranial or intracranial stenting.","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"noi180108r18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.114.014791","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-year outcomes.","volume":"132","author":"Wang","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"noi180108r19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ahj.2010.05.017","article-title":"Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event.","volume":"160","author":"Wang","year":"2010","journal-title":"Am Heart J"},{"issue":"10","key":"noi180108r20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.","volume":"329","author":"GUSTO investigators","year":"1993","journal-title":"N Engl J Med"},{"issue":"4","key":"noi180108r21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5607\/en.2012.21.4.164","article-title":"Association between ABCB1 polymorphisms and ischemic stroke in Korean population.","volume":"21","author":"Kim","year":"2012","journal-title":"Exp Neurobiol"},{"issue":"8","key":"noi180108r22","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/gim.2015.171","article-title":"Evaluation of the incremental prognostic value of the combination of CYP2C19 poor metabolizer status and ABCB1 3435 TT polymorphism over conventional risk factors for cardiovascular events after drug-eluting stent implantation in East Asians.","volume":"18","author":"Park","year":"2016","journal-title":"Genet Med"},{"issue":"18","key":"noi180108r23","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJMoa1008410","article-title":"Effects of CYP2C19 genotype on outcomes of clopidogrel treatment.","volume":"363","author":"Par\u00e9","year":"2010","journal-title":"N Engl J Med"},{"issue":"10","key":"noi180108r24","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.1007\/s11033-014-3590-y","article-title":"Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population.","volume":"41","author":"Vargas-Alarc\u00f3n","year":"2014","journal-title":"Mol Biol Rep"},{"key":"noi180108r25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2350-12-13","article-title":"CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population.","volume":"12","author":"Santos","year":"2011","journal-title":"BMC Med Genet"},{"issue":"3","key":"noi180108r26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA.","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaneurology\/article-pdf\/76\/5\/552\/17579700\/jamaneurology_pan_2019_oi_180108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T15:02:34Z","timestamp":1557759754000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2018.4775"}},"subtitle":["Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2018.4775","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}